Infignos Media -- buyersUSA Consulting
NOW PLAYING
15 Radio Streams
Click Here
Brown's Radiator and A/C Service
Advertise Here

From Government, Legal and Policy - Legal Issues

Brought to you by Frontera Bar & Grill

Mexican quisine at it's finest. For lunch, dinner or take out, visit Frontera Bar & Grill 1750 Hamric Dr E Oxford, AL 36203? (256) 835-9905

Bladder Control

CRESTOR US Patent Upheld by Court of Appeals for the Federal Circuit

Mon, 17 Dec 2012 10:47:29 EST

AstraZeneca announced today that the Court of Appeals for the Federal Circuit has upheld the decision of the District Court, District of Delaware, finding that the US substance patent protecting CRESTOR (rosuvastatin calcium) (RE37,314 – the '314 patent) is valid and enforceable. The defendants may seek a rehearing and/or review by the U.S. Supreme Court. Absent a reversal of this decision, none of the Abbreviated New Drug Applications (ANDAs) filed by Apotex, Aurobindo, Cobalt, Glenmark, Mylan, Par, Sandoz, Sun, Teva and Torrent may be approved by the FDA prior to expiration of the '314 patent. The '314 patent, which expires in 2016, covers rosuvastatin calcium, the active ingredient in CRESTOR.

The Federal Circuit also held that Apotex Corp. was liable as a submitter and is therefore bound by the District Court's decision.

NOTES TO EDITORS

About the Trial

Beginning in 2007, nine generic drug manufacturers filed ANDAs along with Paragraph IV certifications of non-infringement, invalidity, or unenforceability with respect to the CRESTOR '314 substance patent. AstraZeneca and Shionogi (the owner of the '314 patent) filed patent infringement suits against eight manufacturers (various parent or subsidiary entities of Apotex, Aurobindo, Cobalt, Mylan, Par, Sandoz, Sun and Teva) who had challenged the '314 substance patent. These suits were consolidated by order of the Judicial Panel on Multidistrict Litigation and tried in the U.S. District Court, District of Delaware. Trial commenced on February 22, 2010 before Judge Farnan and ended on March 3, 2010.

In June 2010, the US District Court for the District of Delaware found the '314 patent valid and enforceable and infringed by the eight generic defendants.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.


Source: WebWire



From Our Blogs

Naked Man Plus Home for Sale Equals Lots of Views

Adorable funny video featuring local actors...

Back-to-School Shopping on a Budget

To make the back-to-school season easier and more affordable, do get your game plan together.

How to Network Your Way to a Great New Job

Social media is not a substitute for face-to-face communication.

This School Year, Raise Grades with Online Learning Tools

There are great ways you can help make this school year the best one yet.


Sign up for our weekly newsletter.

Our Website Sponsors

Transformation Technologies

Improve your golf scores. View our free 16 minute golf course at golf.transformationsolutions.com

Oxford Lumber

Neighborhood service and warehouse prices since 1958. We're also proud to own and operate Roanoke Ace Home Center, Talladega Ace Home Center and Jacksonville Home Center. Oxford Lumber is located at 1400 Barry Street. Call 256-831-0540

Frontera Bar & Grill

Mexican quisine at it's finest. For lunch, dinner or take out, visit Frontera Bar & Grill 1750 Hamric Dr E Oxford, AL 36203? (256) 835-9905

Signature In Home Care

Our mission is to help seniors remain independent in their homes as long as possible by offering quality, affordable care. We can also provide a helping hand with activities of daily living. Call 1-877-777-1822 or 256-831-3250

Miller Funeral Home and Crematory

For pre-planning or immediate funeral services call us at 256-831-4611 or visit www.millerfuneralhomeoxford.com.